ABG-WTT Global Life Science Capital Partners GP Ltd

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), ABG-WTT Global Life Science Capital Partners GP Ltd reported 4 stock positions worth $43.7 million. Its top holding was Ceribell (CBLL) at 64.4% of the portfolio, followed by CG Oncology (CGON, 32.5%) and Rapid Micro Biosystems Class A (RPID, 2.1%). Compared with Q3 2024, it opened 1 new position. The biggest buy was a new position in Ceribell (CBLL).

Most Recent 13F
Q2 2026
Location
CENTRAL, HONG KONG, K3
CIK
0001832108
Portfolio Value
$43.7M (Q4 2024)
SEC Filing
0000950123-25-002368 ↗ filed Feb 14, 2025

Holdings Value

0$10.0M$20.0M$30.0M$40.0M$50.0M Q1 2024: $41.5M Q1 2024 Q2 2024: $30.0M Q2 2024 Q3 2024: $20.1M Q3 2024 Q4 2024: $43.7M $43.7M Q4 2024 Q1 2025: $38.3M Q1 2025 Q2 2025: $26.8M Q2 2025 Q3 2025: $18.7M Q3 2025 Q4 2025: $15.0M Q4 2025 Q1 2026: $12.3M Q1 2026 Q2 2026: $8.6M Q2 2026

Holdings 4 stocks · $43.7M
CBLL Ceribell Inc. 64.42% 1,088,101 $28.2M New
CGON CG Oncology Inc. 32.51% 495,526 $14.2M No change
RPID Rapid Micro Biosystems Inc. Class A 2.14% 1,038,296 $934K No change
LUNG Pulmonx Corp. 0.94% 60,204 $409K No change

Portfolio Sells Q3 2024 → Q4 2024
None this quarter.

Portfolio Buys Q3 2024 → Q4 2024
CBLL Ceribell Inc. New 64.42% +64.42

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$8.6MCBLL, RPID
Q1 2026 2$12.3MCBLL, RPID
Q4 2025 2$15.0MCBLL, RPID
Q3 2025 2$18.7MCBLL, RPID
Q2 2025 2$26.8MCBLL, RPID
Q1 2025 4$38.3MCBLL, CGON, RPID, LUNG
Q4 2024 4$43.7MCBLL, CGON, RPID, LUNG
Q3 2024 3$20.1MCGON, RPID, LUNG
Q2 2024 3$30.0MCGON, RPID, LUNG
Q1 2024 3$41.5MCGON, RPID, LUNG